These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 3516291)
1. Effects of intravenous and subcutaneous administration of apomorphine on the clinical symptoms of chronic schizophrenics. Syvälahti EK; Säkö E; Scheinin M; Pihlajamäki K; Hietala J Br J Psychiatry; 1986 Feb; 148():204-8. PubMed ID: 3516291 [TBL] [Abstract][Full Text] [Related]
2. Apomorphine and schizophrenia. Treatment, CSF, and neuroendocrine responses. Levy MI; Davis BM; Mohs RC; Kendler KS; Mathé AA; Trigos G; Horvath TB; Davis KL Arch Gen Psychiatry; 1984 May; 41(5):520-4. PubMed ID: 6372737 [TBL] [Abstract][Full Text] [Related]
3. Effects of dopamine agonists in tardive dyskinesia. Smith RC; Tamminga CA; Haraszti J; Pandey GN; Davis JM Am J Psychiatry; 1977 Jul; 134(7):763-8. PubMed ID: 869053 [TBL] [Abstract][Full Text] [Related]
4. Oxprenolol in schizophrenic patients with tardive dyskinesia: a double-blind placebo-controlled, crossover study. Karniol IG; Portela W Braz J Med Biol Res; 1982 Dec; 15(6):389-94. PubMed ID: 6135468 [TBL] [Abstract][Full Text] [Related]
5. Schizophrenic symptoms improve with apomorphine. Tamminga CA; Schaffer MH; Smith RC; Davis JM Science; 1978 May; 200(4341):567-8. PubMed ID: 347574 [TBL] [Abstract][Full Text] [Related]
6. Midification of tardive dyskinesia and spasmodic torticollis by apomorphine. Possible role of dopamine autoreceptors. Tolosa ES Arch Neurol; 1978 Jul; 35(7):459-62. PubMed ID: 666598 [TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine effects of apomorphine in chronic schizophrenic patients under long-term neuroleptic therapy and after drug withdrawal: relations to psychopathology and tardive dyskinesia. Müller-Spahn F; Ackenheil M; Albus M; May G; Naber D; Welter D; Zander K Psychopharmacology (Berl); 1984; 84(3):436-40. PubMed ID: 6151210 [TBL] [Abstract][Full Text] [Related]
9. Levodopa-induced diphasic dyskinesias improved by subcutaneous apomorphine. de Saint Victor JF; Pollak P; Gervason CL; Perret J Mov Disord; 1992; 7(3):283-4. PubMed ID: 1620148 [No Abstract] [Full Text] [Related]
10. Effect of apomorphine on schizophrenic symptoms. Smith RC; Tamminga C; Davis JM J Neural Transm; 1977; 40(2):171-6. PubMed ID: 323423 [TBL] [Abstract][Full Text] [Related]